Diagnostic and prognostic significance of receptor-binding cancer antigen expressed on SiSo cells in lung-cancer-associated pleural effusion
|
|
- Laura Powers
- 5 years ago
- Views:
Transcription
1 Received: 1 May 2016 Revised: 19 June 2016 Accepted: 10 July 2016 DOI: /crj ORIGINAL ARTICLE Diagnostic and prognostic significance of receptor-binding cancer antigen expressed on SiSo cells in lung-cancer-associated pleural effusion Jian Yang 1 * Ying Zhu 1 * Liangquan Wu 1 Wenyan Zhu 1 Xiuwei Zhang 1 Yang Yang 1 Chunhua Xu 2,3 1 Department of Respiratory Medicine, Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu , China 2 Endoscopic Center of Nanjing Chest Hospital, Nanjing, Jiangsu , China 3 Clinical Center of Nanjing Respiratory Diseases and Imaging, Nanjing, Jiangsu , China Correspondence Xiu Wei Zhang, Department of Respiratory Medicine, Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu , China. zhangxiuwei_nj@163.com Chunhua Xu, Endoscopic Center of Nanjing Chest Hospital, Nanjing, Jiangsu , China. xuchunhua74@163.com Abstract Objectives: This study aimed to evaluate the diagnostic and prognostic value of pleural effusion levels of soluble receptor-binding cancer antigen expressed on SiSo cells (srcas1) in lung cancer patients with malignant pleural effusion (MPE). Methods: Pleural effusion samples were collected from 78 patients with MPE, and from 48 patients with benign pleural effusion (BPE). Pleural effusion srcas1 concentrations were measured by enzyme-linked immunosorbent assay. Results: MPE has significantly higher srcas1 levels than that of BPE (P <.01). With a cutoff value of 18.7 U/mL, srcas1 showed a good diagnostic performance for MPE. Univariate and multivariate analysis indicated that elevated srcas1 levels were an independent predictor of overall survival (OS) and disease-free survival (DFS). Kaplan Meier survival curves further confirmed that patients with high srcas1 have shorter DFS and OS (P and P 5.032, respectively). Conclusion: In conclusion, measurement of srcas1 might be a useful diagnostic and prognostic marker for MPE. KEYWORDS diagnosis, lung cancer, pleural effusion, prognosis, srcas1 Jian Yang and Ying Zhu are equal contributors. 1 INTRODUCTION Malignant pleural effusion (MPE) defines effusion from infiltration of the pleura by cancer cells. 1,2 The incidence of lung cancer patients with malignant effusion is 7% 23%. 3 Patients with malignant effusion have a short life and are difficult to be treated effectively. The management of MPE patients requires effective treatment based on timely and accurate diagnosis. In addition to diagnostic issues, patients with MPE are difficult to treat effectively and have a poor prognosis. Despite advances in treatment modalities, the survival remains still short. The present standard treatment is evacuation of the pleural fluid followed by intrapleural chemotherapy or intravenous chemotherapy. 4 However, it was found that not all patients were benefited from the chemotherapy. Therefore, prognostic assessment of the patient is necessary. Recently, molecular studies identified several markers as prognostic factors for pleural effusion. 5 Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) is present in various human cell lines. 6 In previous studies, RCAS1 was expressed in various malignant tissues, Clin Respir J. 2018;12: wileyonlinelibrary.com/journal/crj VC 2016 John Wiley & Sons Ltd 279
2 280 YANG ET AL. 2.2 Sample collection and determination of srcas1 concentrations Each sample of pleural fluid was collected in a syringe during a thoracentesis performed after written informed consent was obtained. Samples were centrifuged at 2,000 revolutions/min for 10 min, and the supernatant was frozen at 2808C until assayed. Soluble RCAS1 levels were measured by sandwich enzyme-linked immunosorbent assay using commercially available kits (Medical and Biological Laboratories Co Ltd, China). FIGURE 1 Levels of pleural effusion srcas1 in lung cancer patients with MPE. Among 78 lung cancer patients with MPE, the pleural effusion levels of srcas1 were ( ) U/mL, which were significantly higher than ( ) U/mL in patients with BPE (*P <.01) including lung cancer. 7,8 Soluble RCAS1 has been detected in a culture supernatant derived from a human bile duct carcinoma cell line. 9 There are few studies based on small numbers of patients have suggested that elevated pleural effusion srcas1 levels are associated with poor prognosis of pleural effusion patients. 10 Therefore, we presently studied 126 patients with pleural effusions to determine whether pleural fluid srcas1 levels could be used as a diagnostic and prognostic biomarker of lung cancer. We found that srcas1 is elevated in MPE, as well as being potentially predictive of survival outcome. 2.3 Statistical analyses All statistical analyses of differences between MPE and BPE were performed using the Mann Whitney U test. The diagnostic accuracies of sracs1 in discriminating between MPE and BPE were compared by constructing receiver operating characteristic (ROC) curves. Overall survival (OS) time was defined as the time interval from the date of diagnosis to the date of death. Disease-free survival (DFS) time was defined as the time interval from the date of diagnosis to the date of first recurrence. Survival curves were plotted by the Kaplan Meier method and compared using the log-rank test. Survival data were evaluated using univariate and multivariate Cox regression analysis. Values of P <.05 were considered to indicate statistical significance. 2 MATERIALS AND METHODS 2.1 Patients Between January 2012 and December 2014, the pleural effusion was available from126 patients. Diagnosis of lung cancer was histologically or cytologically proven in 78 cases (38 men and 40 women, aged years). In all the patients, cancer cells were found in pleural effusion by cytological evaluation. These patients comprised 60 with adenocarcinomas and 18 with squamous cell carcinomas. Patients with benign disease comprised 40 with tuberculous pleurisie and 8 with empyema (26 men and 22 women, years of age). Histological type was reclassified according to WHO classification, and the stage of tumor was based on pathological tumor-node-metastasis classification (7 th edition) of the International Union against Cancer. 11 Clinicopathological characteristics of the patients were collected by the retrospective review of medical archives. All patients were followed up by interview in hospital or phone call. FIGURE 2 ROC of srcas1 for the diagnosis of lung cancer patients with MPE. Pleural effusion levels of srcas1 among 78 lung cancer patients with MPE and 48 patients with BPE were determined. The diagnostic potentials of srcas1 were assessed by ROC curves. The AUC value was.947
3 YANG ET AL. 281 TABLE 1 Relationship between pleural effusion srcas1 levels and clinicopathologic characteristics in lung cancer patients with MPE Characteristics All cases srcas1 (U/mL) P Total Age (years) > Gender Male Female Histology Adenocarcinoma Squamous Lymph node metastasis Positive a Negative Tumor size >3 cm cm Tumor grade Poor Well-moderate Distant metastasis Positive a Negative a Significant difference. 3 RESULTS 3.1 Levels of srcas1 in pleural effusion The levels of srcas1 in pleural effusion were measured by ELISA from 78 MPE patients and 48 BPE patients. The levels of srcas1 were significantly higher in MPE patients compared with those in BPE patients ( vs U/mL, P <.01) (Figure 1). 3.2 Diagnostic value of srcas1 in patients with malignant effusion FIGURE 3 Overall survival (OS) and disease-free survival (DFS) curves according to pleural effusion srcas1 levels in lung cancer patients with MPE. (A) OS and (B) DFS stratified by srcas1 level. Cutoff points are 18.7 U/mL for srcas1. Log-rank test determined that the DFS and OS in high srcas1 group were significantly shorter than those in the low srcas1 group (P 5.026; P 5.032) An ROC curve analysis was carried out to assess the value of srcas1 in lung cancer patients with MPE. The area under the ROC curve was (95% CI (confidence interval), ). The best efficacy was observed at 18.7 U/ ml. Using a cutoff point of 18.7 U/mL, srcas1 had a sensitivity of 64.1%, a specificity of 85.4%, and an accuracy of 72.2% (Figure 2). 3.3 Relationship between pleural effusion srcas1 levels and clinicopathologic characteristics in patients with malignant effusion The relationships between srcas1 levels and clinicopathologic characteristics of lung cancer patients are shown in Table 1. The levels of srcas1 were significantly correlated with lymph node metastasis (P 5.034) and distant metastasis (P 5.006). Nevertheless, there were no significant correlation between srcas1 levels and other clinicopathological characteristics including age, gender, histological type, and tumor grade.
4 282 YANG ET AL. TABLE 2 Univariate and multivariate Cox proportional hazards model for OS and DFS in lung cancer patients with MPE Variables Univariate Multivariate HR 95% CI P HR 95% CI P OS Age (>60 vs 60 years) Gender (male vs female) Histology(adenocarcinoma vs squamous) Lymph node metastasis (positive vs negative) < Tumor size (>3 cmvs3 cm) Grade (poor vs well-moderate) Distant metastasis (positive vs negative) < <.001 srcas1 (18.7 U/mL vs <18.7 U/mL) < <.001 DFS Age (>60 vs 60 years) Gender (male vs female) Histology (adenocarcinoma vs squamous) Lymph node metastasis (positive vs negative) < Tumor size (>3 cmvs3 cm) Grade (poor vs well-moderate) Distant metastasis (positive vs negative) < <.001 srcas1 (18.7 U/mL vs <18.7 U/mL) < <.001 Abbreviations: CI, confidence interval; DFS, disease-free survival; HR, hazard ratio; OS, overall survival. 3.4 Association of pleural effusion srcas1 levels with survival Using a cutoff point of 18.7 U/mL, patients were divided into high and low pleural effusion parameter groups. As shown in Figure 3, 1 year OS and DFS analysis in the overall patient population showed a shorter OS and DFS for patients with high srcas1 levels as compared with those patients with low srcas1 levels (log rank test, P for OS, P for DFS, respectively). As shown in Table 2, univariate analysis revealed that histological subtype (P for OS and P for DFS), lymph node metastasis (P <.001 for OS and DFS), distant metastasis (P <.001 for OS and DFS), and srcas1 levels (P <.001 for OS and DFS), were significantly associated with poor prognosis. Multivariate analysis showed that srcas1 was independent prognostic factors for OS and DFS. 4 DISCUSSION To the best of our knowledge, this is the first study on pleural effusion in which srcas1 levels were simultaneously investigated for their diagnostic and prognostic power of MPE. Our findings suggest that elevated pleural effusion concentrations of srcas1 correlated with shorter survival in patients with MPE. Furthermore, multivariate analysis of prognostic factors identified pleural effusion srcas1 concentration as an independent prognostic factor for overall survival in MPE. These results suggest that pleural effusion srcas1 level is an indicator for both presence of MPE and survival outcome. RCAS1 is important in tumor progression or metastasis. Recent studies showed RCAS1 was expressed in various cancers RCAS1 expression also has been associated with poor differentiation and advanced stage. 15,16 Furthermore, RCAS1 expression was reported to be related to overall survival of patients with cancers of the lung, esophagus, and stomach. 7,8,12,16 Thus, the level of RCAS1 may indicate the aggressiveness of human tumors behavior. However, the prognostic value of srcas1 in MPE remains few. 10,19 The rational for investigating srcas1 as the prognostic markers in MPE is based on its ability to promote proliferation. A lot of reports have shown that high level of srcas1 in tumor is associated with adverse outcome in patients with
5 YANG ET AL. 283 different types of cancer. In our study, we demonstrated that high pleural effusion srcas1 level was correlated with the poorer OS and DFS. Moreover, we demonstrated that by using multivariate analysis with OS and DFS, srcas1 showed to be the independent prognostic factor for MPE. Differentiating MPE from BPE is a clinical problem, and conventional methods have proven inadequate. 20,21 Areliable marker for diagnosis of pleural effusion is urgently needed. In this study, the srcas1 concentrations in MPE were higher than those in BPE. Our results suggest that srcas1 should be a tumor marker for the diagnosis of MPE. The diagnostic value of srcas1 in MPE was 18.7 U/ml and had a sensitivity of 64.1%, a specificity of 85.4%. This shows that the srcas1 is a valuable marker in the differential diagnosis of MPE and BPE. In conclusion, srcas1 concentrations in MPE were significantly higher than those in BPE. Determination of srcas1 concentration in the pleural effusion is diagnostically informative, while srcas1 concentration is an independent prognostic factor that shows promise in follow-up of lung cancer patients who develop effusion. CONFLICT OF INTEREST The authors declare no any conflicts of interest in this work. AUTHOR CONTRIBUTIONS Study design: Xiuwei Zhang, Chunhua Xu Data collection: Jian Yang, Ying Zhu, Liangquan Wu, Wenyan Zhu Manuscript writing and study performance: Chunhua Xu, Yang Yang ETHICS This research was approved by the Ethics Committee of the Jiangning Hospital. All patients gave their informed consents. REFERENCES [1] Roberts ME, Neville E, Berrisford RG, et al. Management of malignant pleural effusion: British Thoracic Society Pleural Disease Guideline Thorax. 2010; 65:ii32 ii40. [2] Heffner JE, Klein JS. Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc. 2008;83: [3] Cheng D, Kong H, Li YH. Prognostic values of VEGF and IL-8 in malignant pleural effusion in patients with lung cancer. Biomarkers. 2013;18: [4] Su WC, Lai WW, Chen HH, et al. Combined intrapleural and intravenous chemotherapy, and pulmonary irradiation, for treatment of patients with lung cancer presenting with malignant pleural effusion. A pilot study. Oncology. 2003;64: [5] Hsu IL, Su WC, Yan JJ, et al. Angiogenetic biomarkers in non-small-cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control. Lung Cancer. 2009;65: [6] Nakashima T, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med. 1999; 5: [7] Xu CH, Zhan P, Zhang Y, Yu LK. Serum-soluble receptor-binding cancer antigen expressed on SiSo cells as a clinical marker in lung cancer. Tumour Biol. 2014; 35: [8] Timotheadou E, Skarlos DV, Samantas E, et al. Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small-cell lung cancer patients. Anticancer Res. 2007;27: [9] Enjoji M, Nakashima M, Nishi H, et al. The tumorassociated antigen, RCAS1, can be expressed in immunemediated disease as well as in carcinomas of biliary tract. J Hepatol. 2002;36: [10] Aoe K, Hiraki A, Yamazaki K, et al. Elevated pleural fluid RCAS1 is a diagnostic marker and outcome predictor in lung cancer patients. Int J Oncol. 2006;29: [11] Groome PA, Bolejack V, Crowley JJ, et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2: [12] Coban S, Ozkan H, K okl u S, et al. The utility of serum receptor-binding cancer antigen expressed on SiSo cells in gastrointestinal tract cancers. Can J Gastroenterol. 2006;20: [13] Popiela TJ, Rudnicka-Sosin L, Dutsch-Wicherek M, et al. The metallothionein and RCAS1 expression analysis in breast cancer and adjacent tissue regarding the immune cells presence and their activity. Neuro Endocrinol Lett. 2006;27: [14] Enjoji M, Nakashima M, Yamaguchi K, et al. Significance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas. J Gastroenterol Hepatol. 2005;20: [15] Ozkan H, Akar T, K okl u S, etal. Significance of serum receptor-binding cancer antigen (RCAS1) in pancreatic cancer and benign pancreatobiliary diseases. Pancreatology. 2006;6: [16] Giaginis C, Efkarpidis T, Alexandrou P, et al. Increased RCAS1 expression is associated with advanced histopathological stage and poor prognosis in patients with gastric adenocarcinoma. Dis Markers. 2013;35:
6 284 YANG ET AL. [17] Nakamura Y, Yamazaki K, Oizumi S, et al. Expression of RCAS1 in human gastric carcinoma: a potential mechanism of immune escape. Cancer Sci. 2004;95: [18] Rupesh P, Manoj P, Vijay Kumar S. Biomarkers in carcinoma of the gallbladder. Expert Opin Med Diagn. 2008; 2: [19] Hiraki A, Aoe K, Murakami T, et al. Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma. Oncol Rep. 2005;14: [20] Aoe K, Hiraki A, Murakami T, et al. Diagnostic significance of interferon-gamma in tuberculous pleural effusions. Chest. 2003;123: [21] Hiraki A, Aoe K, Eda R, et al. Comparison of six biological markers for the diagnosis of tuberculous pleuritis. Chest. 2004;125: How to cite this article: Yang J, Zhu Y, Wu L, et al. Diagnostic and prognostic significance of receptorbinding cancer antigen expressed on SiSo cells in lungcancer-associated pleural effusion. Clin Respir J. 2018;12:
Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer Yangki Seok 1, Ji Yun Jeong 2 & Eungbae
More informationCharacteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases Mei Li & Zhi-xiong Lin Department of Radiation
More informationOriginal Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical outcome
Int J Clin Exp Pathol 2017;10(2):2030-2035 www.ijcep.com /ISSN:1936-2625/IJCEP0009456 Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical
More informationPulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy
European Journal of Cardio-Thoracic Surgery 41 (2012) 25 30 doi:10.1016/j.ejcts.2011.04.010 ORIGINAL ARTICLE Pulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy
More informationHigh expression of fibroblast activation protein is an adverse prognosticator in gastric cancer.
Biomedical Research 2017; 28 (18): 7779-7783 ISSN 0970-938X www.biomedres.info High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer. Hu Song 1, Qi-yu Liu 2, Zhi-wei
More informationSupplementary Information
Supplementary Information Prognostic Impact of Signet Ring Cell Type in Node Negative Gastric Cancer Pengfei Kong1,4,Ruiyan Wu1,Chenlu Yang1,3,Jianjun Liu1,2,Shangxiang Chen1,2, Xuechao Liu1,2, Minting
More informationClinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05
Abstract No.: ABS-0075 Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer 2018/04/05 Cheol Min Kang Department of surgery, University of Ulsan
More informationThe Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer
Original Article The Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer Chen Qiu, MD,* Wei Dong, MD,* Benhua Su, MBBS, Qi Liu, MD,* and Jiajun Du, PhD Introduction:
More informationRatio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer
Original Article Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer Fangfang Chen 1 *, Yanwen Yao 2 *, Chunyan
More informationValidation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer
Original Article Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Hee Suk Jung 1, Jin Gu Lee 2, Chang Young Lee 2, Dae Joon Kim 2, Kyung Young Chung 2 1 Department
More information290 Clin Oncol Cancer Res (2009) 6: DOI /s
290 Clin Oncol Cancer Res (2009) 6: 290-295 DOI 10.1007/s11805-009-0290-9 Analysis of Prognostic Factors of Esophageal and Gastric Cardiac Carcinoma Patients after Radical Surgery Using Cox Proportional
More informationLung cancer is a major cause of cancer deaths worldwide.
ORIGINAL ARTICLE Prognostic Factors in 3315 Completely Resected Cases of Clinical Stage I Non-small Cell Lung Cancer in Japan Teruaki Koike, MD,* Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, Yasunori Sohara,
More informationCancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006
Chinese Journal of Cancer Original Article Cancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006 Xiao-Pan Li 1, Guang-Wen Cao 2, Qiao
More informationLog odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection
Original Article Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection Mingjian Yang 1,2, Hongdian Zhang 1,2, Zhao Ma 1,2, Lei Gong 1,2, Chuangui Chen
More informationExpression of mir-1294 is downregulated and predicts a poor prognosis in gastric cancer
European Review for Medical and Pharmacological Sciences 2018; 22: 5525-5530 Expression of mir-1294 is downregulated and predicts a poor prognosis in gastric cancer Y.-X. SHI, B.-L. YE, B.-R. HU, X.-J.
More informationAlthough the international TNM classification system
Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru
More informationLocoregional treatment Session Oral Abstract Presentation Saulo Brito Silva
Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer
More informationOnly Estrogen receptor positive is not enough to predict the prognosis of breast cancer
Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors
More informationCorrelation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer
Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer X.L. Liu 1, L.D. Liu 2, S.G. Zhang 1, S.D. Dai 3, W.Y. Li 1 and L. Zhang 1 1 Thoracic Surgery,
More informationElevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients
Xu et al. European Journal of Medical Research 2014, 19:23 EUROPEAN JOURNAL OF MEDICAL RESEARCH RESEARCH Open Access Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung
More informationXiang Hu*, Liang Cao*, Yi Yu. Introduction
Original Article Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7 th edition and JCGS 13 th edition N-classification systems Xiang Hu*, Liang
More informationRevisiting Stage IIIB and IV Non-small Cell Lung Cancer. Analysis of the Surveillance, Epidemiology, and End Results Data
CHEST Revisiting Stage IIIB and IV Non-small Cell Lung Cancer Analysis of the Surveillance, Epidemiology, and End Results Data William N. William, Jr, MD; Heather Y. Lin, PhD; J. Jack Lee, PhD; Scott M.
More informationCircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer
European Review for Medical and Pharmacological Sciences 2018; 22: 3713-3718 CircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer N. LIU 1, J. ZHANG 1, L.-Y. ZHANG 1, L.
More informationThe effect of delayed adjuvant chemotherapy on relapse of triplenegative
Original Article The effect of delayed adjuvant chemotherapy on relapse of triplenegative breast cancer Shuang Li 1#, Ding Ma 2#, Hao-Hong Shi 3#, Ke-Da Yu 2, Qiang Zhang 1 1 Department of Breast Surgery,
More informationVisceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size
GENERAL THORACIC Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size Elizabeth David, MD, Peter F. Thall, PhD, Neda Kalhor, MD, Wayne L. Hofstetter,
More informationPrognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis
< A supplementary figure and table are published online only at http://thx.bmj.com/content/ vol65/issue3. 1 Institute of Clinical Medicine, National Yang-Ming University, 2 Department of Surgery, Cathay
More informationLung cancer is now a major cause of death in developed
Original Article New IASLC/ATS/ERS Classification and Invasive Tumor Size are Predictive of Disease Recurrence in Stage I Lung Adenocarcinoma Naoki Yanagawa, MD, PhD,* Satoshi Shiono, MD, PhD, Masami Abiko,
More informationThe Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (9), Page
The Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (9), Page 5298-5303 Prognostic Value of Platelet to Lymphocyte Ratio in Patients with Non-Small Cell Lung Cancer Mohammad Sabry Elkady, Ghada
More informationPrognostic factors in curatively resected pathological stage I lung adenocarcinoma
Original Article Prognostic factors in curatively resected pathological stage I lung adenocarcinoma Yikun Yang 1, Yousheng Mao 1, Lin Yang 2, Jie He 1, Shugeng Gao 1, Juwei Mu 1, Qi Xue 1, Dali Wang 1,
More informationAvailable online at
60 Available online at www.annclinlabsci.org Serum Angiopoietin-2 as a Clinical Marker for Lung Cancer in Patients with Solitary Pulmonary Nodules Chunhua Xu 1,2, Wei Wang 1,2, Yuchao Wang 1,2, Xiuwei
More informationVisceral pleural involvement (VPI) of lung cancer has
Visceral Pleural Involvement in Nonsmall Cell Lung Cancer: Prognostic Significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu, MD, PhD, Sosuke Yamada, MD, and Kosei Yasumoto,
More informationCombined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer
He et al. BMC Gastroenterology 2013, 13:87 RESEARCH ARTICLE Open Access Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer Chao-Zhu He 1,2, Kun-He Zhang
More informationPrognostic value of visceral pleura invasion in non-small cell lung cancer q
European Journal of Cardio-thoracic Surgery 23 (2003) 865 869 www.elsevier.com/locate/ejcts Prognostic value of visceral pleura invasion in non-small cell lung cancer q Jeong-Han Kang, Kil Dong Kim, Kyung
More informationPrognostic Value of Plasma D-dimer in Patients with Resectable Esophageal Squamous Cell Carcinoma in China
1663 Ivyspring International Publisher Research Paper Journal of Cancer 2016; 7(12): 1663-1667. doi: 10.7150/jca.15216 Prognostic Value of Plasma D-dimer in Patients with Resectable Esophageal Squamous
More informationImplications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers
日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu
More informationPrognostic value of tumor length in predicting survival for patients with esophageal cancer
Original Article Prognostic value of tumor length in predicting survival for patients with esophageal cancer Haijing Wang 1, Liangwen Bi 2, Lizhen Zhang 2, Weiyong Zhao 2, Min Yang 1,3, Xinchen Sun 1 1
More informationLung cancer is the leading cause of cancer deaths worldwide.
ORIGINAL ARTICLE Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non Small-Cell Lung Cancer Jung-Jyh Hung, MD, PhD,* Wen-Juei Jeng, MD, Wen-Hu
More informationfollowing radiotherapy
British Journal of Cancer (1995) 72, 1536-154 r) 1995 Stockton Press All rights reserved 7-92/95 $12. Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapy ARM Sproston',
More informationRare Small Cell Carcinoma in Genitourinary Tract: Experience from E-Da Hospital
E-Da Medical Journal 20;():-5 Original Article Rare Small Cell Carcinoma in Genitourinary Tract: Experience from E-Da Hospital Wei-Ting Kuo, I-Wei Chang2, Kevin Lu, Hua-Pin Wang, Tsan-Jung u, Victor C.
More informationRevisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis
Jpn J Clin Oncol 1997;27(5)305 309 Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis -, -, - - 1 Chest Department and 2 Section of Thoracic Surgery,
More informationLow levels of serum mir-99a is a predictor of poor prognosis in breast cancer
Low levels of serum mir-99a is a predictor of poor prognosis in breast cancer J. Li 1, Z.J. Song 2, Y.Y. Wang 1, Y. Yin 1, Y. Liu 1 and X. Nan 1 1 Tumor Research Department, Shaanxi Provincial Tumor Hospital,
More informationExpression of long non-coding RNA linc-itgb1 in breast cancer and its influence on prognosis and survival
European Review for Medical and Pharmacological Sciences 2017; 21: 3397-3401 Expression of long non-coding RNA linc-itgb1 in breast cancer and its influence on prognosis and survival W.-X. LI 1, R.-L.
More informationVisceral pleura invasion (VPI) was adopted as a specific
ORIGINAL ARTICLE Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival Its Implications for the Forthcoming TNM Staging Based on a Large-Scale Nation-Wide Database Junji Yoshida,
More informationPrognostic value of visceral pleural invasion in resected non small cell lung cancer diagnosed by using a jet stream of saline solution
Maruyama et al General Thoracic Surgery Prognostic value of visceral pleural invasion in resected non small cell lung cancer diagnosed by using a jet stream of saline solution Riichiroh Maruyama, MD Fumihiro
More informationAccepted Manuscript. Risk stratification for distant recurrence of resected early stage NSCLC is under construction. Michael Lanuti, MD
Accepted Manuscript Risk stratification for distant recurrence of resected early stage NSCLC is under construction Michael Lanuti, MD PII: S0022-5223(17)32392-9 DOI: 10.1016/j.jtcvs.2017.10.063 Reference:
More informationThe right middle lobe is the smallest lobe in the lung, and
ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,
More informationImpact of esophageal cancer staging on overall survival and disease-free survival based on the 2010 AJCC classification by lymph nodes
Journal of Radiation Research, 2013, 54, 307 314 doi: 10.1093/jrr/rrs096 Advance Access Publication 2 November 2012 Impact of esophageal cancer staging on overall survival and disease-free survival based
More informationClinical Study Metastasectomy of Pulmonary Metastases from Osteosarcoma: Prognostic Factors and Indication for Repeat Metastasectomy
Respiratory Medicine Volume 2015, Article ID 570314, 5 pages http://dx.doi.org/10.1155/2015/570314 Clinical Study Metastasectomy of Pulmonary Metastases from Osteosarcoma: Prognostic Factors and Indication
More informationRESEARCH COMMUNICATION
DOI:http://dx.doi.org/10.7314/APJCP.2012.13.1.199 RESEARCH COMMUNICATION Prognostic Significance of CYFRA21-1, CEA and Hemoglobin in Patients with Esophageal Squamous Cancer Undergoing Concurrent Chemoradiotherapy
More informationThe accurate assessment of lymph node involvement is
ORIGINAL ARTICLE Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage Classification? Shenhai Wei, MD, PhD,*
More informationNatural History and Treatment Trends in Hepatocellular Carcinoma Subtypes: Insights From a National Cancer Registry
2015;112:872 876 Natural History and Treatment Trends in Hepatocellular Carcinoma Subtypes: Insights From a National Cancer Registry PETER L. JERNIGAN, MD, KOFFI WIMA, MS, DENNIS J. HANSEMAN, PhD, RICHARD
More informationLung cancer pleural invasion was recognized as a poor prognostic
Visceral pleural invasion classification in non small cell lung cancer: A proposal on the basis of outcome assessment Kimihiro Shimizu, MD a Junji Yoshida, MD a Kanji Nagai, MD a Mitsuyo Nishimura, MD
More informationSignificance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories
Original Article Significance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories Wu Song, Yulong He, Shaochuan Wang, Weiling
More informationPrognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer
CHEST Original Research Prognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer Jung-Jyh Hung, MD, PhD ; Wen-Juei Jeng, MD ; Wen-Hu
More informationHyponatremia in small cell lung cancer is associated with a poorer prognosis
Original Article Hyponatremia in small cell lung cancer is associated with a poorer prognosis Wenxian Wang 1, Zhengbo Song 1,2, Yiping Zhang 1,2 1 Department of Chemotherapy, Zhejiang Cancer Hospital,
More informationTitle:Identification of a novel microrna signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis
Author's response to reviews Title:Identification of a novel microrna signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis Authors: Mei-Yin Zhang (zhangmy@sysucc.org.cn) Shu-Hong
More informationChibueze Onyemkpa 1, Alan Davis 1, Michael McLeod 1, Tolutope Oyasiji 1,2. Original Article
Original Article Typical carcinoids, goblet cell carcinoids, mixed adenoneuroendocrine carcinomas, neuroendocrine carcinomas and adenocarcinomas of the appendix: a comparative analysis of survival profile
More informationNode-Negative Non-small Cell Lung Cancer
ORIGINAL ARTICLE Node-Negative Non-small Cell Lung Cancer Pathological Staging and Survival in 1765 Consecutive Cases Benjamin M. Robinson, BSc, MBBS, Catherine Kennedy, RMRA, Jocelyn McLean, RN, MN, and
More informationTemporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008
Special Report Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008 Matthew B. Schabath, PhD, Zachary J. Thompson, PhD,
More informationCorrelation between serum level of chemokine (C-C motif) ligand 18 and poor prognosis in breast cancer
Correlation between serum level of chemokine (C-C motif) ligand 18 and poor prognosis in breast cancer J.H. Sun 1, N. Fan 2 and Y. Zhang 1 1 Xianyang Hospital of Yan an University Clinical Laboratory,
More informationCharacteristics of intramural metastasis in gastric cancer. Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu
ORIGINAL ARTICLE Characteristics of intramural metastasis in gastric cancer Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu Hishima Author for correspondence: T. Hashimoto
More informationPrognostic significance of stroma tumorinfiltrating lymphocytes according to molecular subtypes of breast cancer
Prognostic significance of stroma tumorinfiltrating lymphocytes according to molecular subtypes of breast cancer Hee Jung Kwon, Nuri Jang, Min Hui Park, Young Kyung Bae Department of Pathology, Yeungnam
More informationUpper urinary tract urothelial carcinomas (UTUC)
Prognostic Role of Lymphovascular Invasion in Patients with Urothelial Carcinoma of the Upper Urinary Tract Manel Mellouli 1 *, Slim Charfi 1, Walid Smaoui 2, Rim Kallel 1, Abdelmajid Khabir 1, Mehdi Bouacida
More informationEvaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution
Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution Kotaro Kameyama, MD, a Mamoru Takahashi, MD, a Keiji Ohata, MD, a
More informationPrognostic Factors of Pathologic Stage IB Non-small Cell Lung Cancer
Ann Thorac Cardiovasc Surg 2011; 17: 58 62 Case Report Prognostic Factors of Pathologic Stage IB Non-small Cell Lung Cancer Motoki Yano, MD, Hidefumi Sasaki, MD, Satoru Moriyama, MD, Osamu Kawano MD, Yu
More informationOriginal Article Tissue expression level of lncrna UCA1 is a prognostic biomarker for colorectal cancer
Int J Clin Exp Pathol 2016;9(4):4241-4246 www.ijcep.com /ISSN:1936-2625/IJCEP0012296 Original Article Tissue expression level of lncrna UCA1 is a prognostic biomarker for colorectal cancer Hong Jiang,
More informationIntraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer
Intraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer Yasushi Shintani, MD, hd, a Mitsunori Ohta, MD, hd, a Teruo Iwasaki, MD, hd, a Naoki
More informationCirculating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics Jie Zhang, Jing Gao, Yanyan
More informationDownregulation of serum mir-17 and mir-106b levels in gastric cancer and benign gastric diseases
Brief Communication Downregulation of serum mir-17 and mir-106b levels in gastric cancer and benign gastric diseases Qinghai Zeng 1 *, Cuihong Jin 2 *, Wenhang Chen 2, Fang Xia 3, Qi Wang 3, Fan Fan 4,
More informationClinical profiles and trend analysis of newly diagnosed lung cancer in a tertiary care hospital of East China during
Original Article Clinical profiles and trend analysis of newly diagnosed lung cancer in a tertiary care hospital of East China during 2011 2015 Pingli Wang 1 *, Jixia Zou 1 *, Jingni Wu 1 *, Chengyan Zhang
More informationCase Report Five-Year Survival after Surgery for Invasive Micropapillary Carcinoma of the Stomach
Case Reports in Surgery Volume 2013, Article ID 560712, 4 pages http://dx.doi.org/10.1155/2013/560712 Case Report Five-Year Survival after Surgery for Invasive Micropapillary Carcinoma of the Stomach Shigeo
More informationPredictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer
Original Article Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer Feichao Bao, Ping Yuan, Xiaoshuai Yuan, Xiayi Lv, Zhitian Wang, Jian Hu Department
More informationORIGINAL ARTICLE. International Journal of Surgery
International Journal of Surgery (2013) 11(S1), S90 S94 Contents lists available at ScienceDirect International Journal of Surgery journal homepage: www.journal-surgery.net ORIGINAL ARTICLE Lymph node
More informationThe clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population
Zhang et al. BMC Cancer (2019) 19:22 https://doi.org/10.1186/s12885-018-5147-2 RESEARCH ARTICLE Open Access The clinicopathological features and treatment modalities associated with survival of neuroendocrine
More informationClinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients
Yonago Acta medica 2012;55:57 61 Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients Hiroaki Saito, Seigo Takaya, Yoji Fukumoto, Tomohiro Osaki, Shigeru Tatebe and Masahide
More informationPrognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China
www.springerlink.com Chin J Cancer Res 23(4):265 270, 2011 265 Original Article Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai,
More informationWHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER?
CANCER STAGING TNM and prognosis in CRC WHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER? Alessandro Lugli, MD Institute of Pathology University of Bern Switzerland Maastricht, June 19
More informationCorrelation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients
1568 Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients LIYING GUO 1, YU ZHANG 2, WEI ZHANG 3 and DILIMINA YILAMU 1 1 Department of
More informationJi-Feng Feng 1,2*, Ying Huang 3 and Qi-Xun Chen 1,2 WORLD JOURNAL OF SURGICAL ONCOLOGY
Feng et al. World Journal of Surgical Oncology 2014, 12:58 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio
More informationExtended multi-organ resection for ct4 gastric carcinoma: A retrospective analysis
Original Article Extended multi-organ resection for ct4 gastric carcinoma: A retrospective analysis 1. Longbin Xiao, 2. Mingzhe Li, 3. Fengfeng Xu, Department of General Surgery I, 4. Huishao Ye, Department
More informationA comparison of clinicopathological features and prognosis in prostate cancer between atomic bomb survivors and control patients
ONCOLOGY LETTERS 14: 299-305, 2017 A comparison of clinicopathological features and prognosis in prostate cancer between atomic bomb survivors and control patients KOICHI SHOJI 1, JUN TEISHIMA 1, TETSUTARO
More informationSoluble CD155 As A Biomarker For Malignant Bone And Soft Tissue Tumors
Soluble CD155 As A Biomarker For Malignant Bone And Soft Tissue Tumors Mikinobu Goto, MD, Akihiko Matsumine, MD,PhD, Tomoki Nakamura, MD PhD, Takao Matsubara, MD PhD, Kunihiro Asanuma, MD,PhD, Toru Oi,
More informationEvaluation of the 7 th edition of the UICC-AJCC tumor, node, metastasis classification for esophageal cancer in a Chinese cohort
Original Article Evaluation of the 7 th edition of the UICC-AJCC tumor, node, metastasis classification for esophageal cancer in a Chinese cohort Yan Huang 1 *, Weigang Guo 2 *, Shiming Shi 1, Jian He
More informationTreatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy
Korean J Hepatobiliary Pancreat Surg 2011;15:152-156 Original Article Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Suzy Kim 1,#, Kyubo
More informationTitle:Number of tumor foci predicts prognosis in papillary thyroid cancer
Author's response to reviews Title:Number of tumor foci predicts prognosis in papillary thyroid cancer Authors: Qing-hai Ji (quningfudan@hotmail.com) Ning Qu (jonathan_qn@163.com) Ling Zhang (zhangling@163.com)
More informationPre-Operative Assesment of Lymphocyte Monocyte Ratio in Ovarian Neoplasms. Athulya Krishna Kumar K.T*, Krishnaraj Upadhyaya and Vineeth G Nair
Original Article DOI: 10.21276/APALM.1919 Pre-Operative Assesment of Lymphocyte Monocyte Ratio in Ovarian Neoplasms Athulya Krishna Kumar K.T*, Krishnaraj Upadhyaya and Vineeth G Nair Department of Pathology,
More informationORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery
Nagoya J. Med. Sci. 79. 37 ~ 42, 2017 doi:10.18999/nagjms.79.1.37 ORIGINAL PAPER Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Naoki Ozeki, Koji
More informationSupplementary Material
1 Supplementary Material 3 Tumour Biol. 4 5 6 VCP Gene Variation Predicts Outcome of Advanced Non-Small-Cell Lung Cancer Platinum-Based Chemotherapy 7 8 9 10 Running head: VCP variation predicts NSCLC
More informationDisclosure of Relevant Financial Relationships
Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS
More informationPredicting prognosis of post-chemotherapy patients with resected IIIA non-small cell lung cancer
Original Article Predicting prognosis of post-chemotherapy patients with resected IIIA non-small cell lung cancer Difan Zheng 1,2#, Yiyang Wang 3#, Yuan Li 2,4, Yihua Sun 1,2 *, Haiquan Chen 1,2 * 1 Department
More informationSurvival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Survival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China Yu-Tao Liu, Xue-Zhi Hao, Jun-Ling Li, Xing-Sheng
More informationCancer Cell Research 19 (2018)
Available at http:// www.cancercellresearch.org ISSN 2161-2609 LncRNA RP11-597D13.9 expression and clinical significance in serous Ovarian Cancer based on TCGA database Xiaoyan Gu 1, Pengfei Xu 2, Sujuan
More informationAn Update: Lung Cancer
An Update: Lung Cancer Andy Barlow Consultant in Respiratory Medicine Lead Clinician for Lung Cancer (West Herts Hospitals NHS Trust) Lead for EBUS-Harefield Hospital (RB&HFT) Summary Lung cancer epidemiology
More informationDiagnostic test pepsinogen I and combination with tumor marker CEA in gastric cancer
IOP Conference Series: Earth and Environmental Science PAPER OPEN ACCESS Diagnostic test pepsinogen I and combination with tumor marker CEA in gastric cancer To cite this article: J Sembiring et al 2018
More informationOriginal Article Up-regulation of mir-10a and down-regulation of mir-148b serve as potential prognostic biomarkers for osteosarcoma
Int J Clin Exp Pathol 2016;9(1):186-190 www.ijcep.com /ISSN:1936-2625/IJCEP0018032 Original Article Up-regulation of mir-10a and down-regulation of mir-148b serve as potential prognostic biomarkers for
More informationA comparison of the proposed classifications for the revision of N descriptors for non-small-cell lung cancer
European Journal of Cardio-Thoracic Surgery 49 (2016) 580 588 doi:10.1093/ejcts/ezv134 Advance Access publication 18 April 2015 ORIGINAL ARTICLE Cite this article as: Lee GD, Kim DK, Moon DH, Joo S, Hwang
More informationPrognostic significance of nemo like kinase in nasopharyngeal carcinoma
MOLECULAR MEDICINE REPORTS 10: 131-136, 2014 Prognostic significance of nemo like kinase in nasopharyngeal carcinoma SIZE CHEN 1,2*, ZHIJIAN MA 3*, XUEMEI CHEN 4 and JIREN ZHANG 1 1 Department of Oncology,
More informationAnalysis of Lymph Node Metastasis Correlation with Prognosis in Patients with T2 Gastric Cancer
Analysis of Lymph Node Metastasis Correlation with Prognosis in Patients with T2 Gastric Cancer Xiaowen Liu 1,2, Ziwen Long 1,2, Hong Cai 1,2, Hua Huang 1,2, Yingqiang Shi 1,2, Yanong Wang 1,2 * 1 Department
More informationA study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric cancer.
Biomedical Research 2018; 29 (2): 365-370 ISSN 0970-938X www.biomedres.info A study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric
More informationPrognostic Impact of Hyperglycemia in Patients with Locally Advanced Squamous Cell Carcinoma of Cervix Receiving Definite Radiotherapy
Prognostic Impact of Hyperglycemia in Patients with Locally Advanced Squamous Cell Carcinoma of Cervix Receiving Definite Radiotherapy 2016.04.08 KCCH 김문홍 DM and prediabetes in cancer Negative impact on
More information